Intellectual and adaptive behaviour functioning in pantothenate kinase-associated neurodegeneration

被引:28
|
作者
Freeman, K.
Gregory, A.
Turner, A.
Blasco, P.
Hogarth, P.
Hayflick, S.
机构
[1] Child Dev & Rehabil Ctr, Portland, OR USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
关键词
brain iron accumulation; cognitive functioning; functional skills; pantothenate kinase-associated neurodegeneration;
D O I
10.1111/j.1365-2788.2006.00889.x
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
Background Pantothenate kinase- associated neurodegeneration (PKAN), an extremely rare autosomal recessive disorder resulting in iron accumulation in the brain, has a diverse phenotypic expression. Based on limited case studies of one or two patients, intellectual impairment is considered part of PKAN. Investigations of cognitive functioning have utilized specific neuropsychological tests, without attention to general intellectual skills or adaptive behaviour. Methods Sixteen individuals with PKAN completed measures of global intellectual functioning, and participants or care providers completed measures of adaptive behaviour skills and day-to-day functional limitations. Clinicians provided global ratings of condition severity. Results Testing with standardized measures documented varied phenotypic expression, with general cognitive skills and adaptive behaviour ranging from high average to well below average. Age of disease onset correlated with measures of intellectual functioning, adaptive functioning and disease severity. Conclusions Findings support previously described clinical impressions of varied cognitive impairment and the association between age of onset and impairment. Further, they add important information regarding the natural history of the disease and suggest assessment strategies for use in treatment trials.
引用
收藏
页码:417 / 426
页数:10
相关论文
共 50 条
  • [1] Pantothenate Kinase-Associated Neurodegeneration
    Hartig, Monika B.
    Prokisch, Holger
    Meitinger, Thomas
    Klopstock, Thomas
    CURRENT DRUG TARGETS, 2012, 13 (09) : 1182 - 1189
  • [3] Pantothenate kinase-associated neurodegeneration is not a synucleinopathy
    Li, A.
    Paudel, R.
    Johnson, R.
    Courtney, R.
    Lees, A. J.
    Holton, J. L.
    Hardy, J.
    Revesz, T.
    Houlden, H.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2013, 39 (02) : 121 - 131
  • [4] Anaesthesia recommendations for Pantothenate kinase-associated neurodegeneration
    Koc, Demet
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2020, 61
  • [5] Pantothenate kinase-associated neurodegeneration in Tunisian families
    Benrhouma, H.
    Kraoua, I.
    Klaa, H.
    Rouissi, A.
    Valente, E. M.
    Turki, I. Benyoussef
    MOVEMENT DISORDERS, 2019, 34 : S611 - S611
  • [6] Transcranial sonography in pantothenate kinase-associated neurodegeneration
    Vladimir S. Kostić
    Marina Svetel
    Milija Mijajlović
    Aleksandra Pavlović
    Milica Ječmenica-Lukić
    Dušan Kozić
    Journal of Neurology, 2012, 259 : 959 - 964
  • [7] Multiple myeloma Pantothenate kinase-associated neurodegeneration
    Muenster, Tino
    Koc, Demet
    Bhattacharjee, Sulagna
    Stoeter, Peter
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2020, 61
  • [8] Precision medicine in pantothenate kinase-associated neurodegeneration
    Mónica álvarez-Córdoba
    Marina Villanueva-Paz
    Irene Villalón-García
    Suleva Povea-Cabello
    Juan M.Suárez-Rivero
    Marta Talaverón-Rey
    Javier Abril-Jaramillo
    Ana Belén Vintimilla-Tosi
    José A.Sánchez-Alcázar
    NeuralRegenerationResearch, 2019, 14 (07) : 1177 - 1185
  • [9] Redesigning therapies for pantothenate kinase-associated neurodegeneration
    Munshi, Muhammad I.
    Yao, Sarah J.
    Ben Mamoun, Choukri
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (03)
  • [10] Transcranial sonography in pantothenate kinase-associated neurodegeneration
    Kostic, Vladimir S.
    Svetel, Marina
    Mijajlovic, Milija
    Pavlovic, Aleksandra
    Jecmenica-Lukic, Milica
    Kozic, Dusan
    JOURNAL OF NEUROLOGY, 2012, 259 (05) : 959 - 964